M Telatar
Overview
Explore the profile of M Telatar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen X, Yang L, Udar N, Liang T, Uhrhammer N, Xu S, et al.
Mamm Genome
. 2016 Aug;
8(2):129-33.
PMID: 27518307
Using a magnetic beads-mediated cDNA selection procedure and a fetal brain expression library, we identified a transcriptional unit within a cosmid positive for the marker D11S384. Pursuit of its full-length...
2.
Erem C, Hacihasanoglu A, Cinel A, Onder Ersoz H, Reis A, Sari A, et al.
J Endocrinol Invest
. 2004 Jul;
27(4):366-9.
PMID: 15233558
Brown tumor is a focal lesion of the bone caused by primary or, less commonly, secondary or tertiary hyperparathyroidism (HPT). While the mandible is the most frequently involved bone in...
3.
Ersoz H, Ukinc K, Baykan M, Erem C, Durmus I, Hacihasanoglu A, et al.
Int J Obes Relat Metab Disord
. 2004 Jan;
28(3):378-83.
PMID: 14724665
Objective: Sibutramine is an effective appetite suppresser agent, but treatment is often complicated with side effects, including palpitations and hypertension. In this study, we aimed to assess the effect of...
4.
Erem C, Ersoz H, Karti S, Ukinc K, Hacihasanoglu A, Deger O, et al.
J Endocrinol Invest
. 2002 May;
25(4):345-50.
PMID: 12030606
Several papers concerning abnormalities of blood coagulation and fibrinolysis during hyperthyroidism, have been published. Increased von Willebrand Factor (vWF) activity and high fibrinogen levels have been reported. However, there is...
5.
Emmanouilides C, Rosen P, Telatar M, Malone R, Bosserman L, Menco H, et al.
Clin Lymphoma
. 2001 Nov;
1(2):146-51; discussion 152-3.
PMID: 11707827
Treatment for extensive indolent lymphoma should provide optimization of efficacy while avoiding excessive toxicity. Rituximab may be an ideal agent to combine with chemotherapy because of its lack of classical...
6.
Erem C, Yildiz R, Kavgaci H, Karahan C, Deger O, Can G, et al.
Diabetes Res Clin Pract
. 2001 Nov;
54(3):203-8.
PMID: 11689275
Objective: The objectives of this study were to determine the prevalence of diabetes mellitus in Trabzon city, Turkey, using standardized diagnostic criteria, and to evaluate associated factors. Methods: A total...
7.
Telatar M, Grody W, Emmanouilides C
Mol Diagn
. 2001 Sep;
6(3):161-8.
PMID: 11571709
Background: PCR is the primary method for detecting minimal residual disease in hematologic cancers. One such gene target is the bcl-2/immunoglobulin heavy chain (IgH) translocation found in a majority of...
8.
Erem C, Kavgaci H, Karahan C, Mocan M, Telatar M
Gynecol Endocrinol
. 2001 Sep;
15(4):293-7.
PMID: 11560103
Maternal thyroid function was investigated in 29 pregnant women with goiter and 51 pregnant women without goiter in the eastern Black Sea region of Turkey, which is an endemic goiter...
9.
Telatar M, Grody W
Mol Genet Metab
. 2000 Sep;
71(1-2):256-60.
PMID: 11001819
No abstract available.
10.
Sari A, Dinc H, Zibandeh A, Telatar M, Gumele H
Invest Radiol
. 1999 Nov;
34(11):718-21.
PMID: 10548384
Objective: To determine whether the intrarenal resistive index (RI) can be used as a predictor in patients with advanced clinical diabetic nephropathy. Methods: Sixty-eight kidneys belonging to 34 patients with...